本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiromic BioPharma, Inc.

0.1601
0.0000
成交量:- -
成交額:- -
市值:- -
市盈率:-0.01
高:0.1601
開:0.1601
低:0.1601
收:0.1601
52周最高:0.1601
52周最低:0.1601
股本:- -
流通股本:- -
量比:1.58
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-26.8188
每股收益(LYR):-64.4213
淨資產收益率:-1129.81%
總資產收益率:-143.47%
市淨率:0.00
市盈率(LYR):0.00

資料載入中...

2020/11/17

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/21

重要事件披露

8-K - Current report
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/06

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/06

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/09/03

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/24

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/05

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/07/21

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/07/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/26

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/11

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/11

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933